Paul Lin’s genetically engineered bacteria would have died if exposed to oxygen. Instead of handling the bacteria in open air, he sticks his hands into thick rubber gloves built into the side of a transparent tank, inspecting a test tube filled with clear yellow liquid. Read more...
Photo: (Ken Shin/Daily Bruin)
A Hilton foundation awarded a $5.44 million grant to the UCLA Fielding School of Public Health for research, officials announced Monday. The Conrad N. Hilton Foundation will fund research about achieving the United Nations’ Sustainable Development Goals, or SDGs, which include reducing poverty and hunger, advancing education and making global cities more sustainable. Read more...
A former UCLA resident doctor filed a lawsuit last month against the University of California Board of Regents and supervisors, alleging her supervisors did not grant her maternity leave and later terminated her residency program because they did not want to accommodate her leg injury. Read more...
Photo: A former UCLA resident doctor alleges her supervisors did not grant her maternity leave and later terminated her residency program because they did not want to accommodate her leg injury. (Daily Bruin file photo)
Rajit Gadh is tackling energy shortage issues by redistributing energy from electric vehicles and solar panels based on consumer needs. Gadh, the director of the UCLA Smart Grid Energy Research Center, is spearheading the development of a new energy distribution network, called smart grid technology. Read more...
Photo: Rajit Gadh, director of the UCLA Smart Grid Energy Research Center, is in charge of developing a new energy distribution network called smart grid technology. (Alejandra Reyes-Velarde/Daily Bruin senior staff)
Misak Khachatryan joined the Youth Movement Against Alzheimer’s when he transferred to UCLA, after seeing how his neighbor’s struggle with severe Alzheimer’s disease affected his family. Read more...
Photo: The Youth Movement Against Alzheimer’s, which began last June, focuses on volunteering, advocacy and fundraising for Alzheimer’s research. (Courtesy of Nihal Satyadev)
UCLA will receive $520 million for selling the rights to a prostate cancer medication that campus researchers helped create, officials announced Friday. The deal granted the royalty rights for Xtandi, a prostate cancer drug, to Royalty Pharma, a pharmaceutical investment company. Read more...